MedCity News January 10, 2025
Ouro Medicines’ drugs deplete disease-driving immune cells, allowing the immune system to reset with naïve cells that don’t attack the body. Monograph Capital founded the startup in partnership with GSK.
Autoimmune disease is an unrelenting attack of the body on itself. Drugs that suppress the immune system quell the attack for a while, but patients need to keep taking these drugs, putting them at risk for complications that come from a chronically suppressed immune system.
What if a patient could just start over with immune cells that don’t target bodily tissue? Ouro Medicine aims to achieve that with a drug candidate that works like an immune system reset button. This program is on track to enter the clinic and the...
Today's Sponsors
Today's Sponsor